002603 Shijiazhuang Yiling Pharmaceutical
- 19.37
- +0.10+0.52%
Shijiazhuang Yiling Pharmaceutical News
Eling Pharmaceutical: Announcement on the extension of the actual controller's partial share pledge
Eling Pharmaceutical: Notice on the pledge and cancellation of the pledge of some of the shares of the actual controller
Yiling Pharmaceutical: Announcement on Approval of the Registration Application for Clinical Trials of the New Traditional Chinese Medicine Lianhua QingCough Granule Drug
Yiling Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the Second Extraordinary General Meeting of Shareholders of Shijiazhuang Yiling Pharmaceutical Co., Ltd. in 2023
Yiling Pharmaceutical: Announcement of Resolutions of the Second Extraordinary General Meeting of Shareholders of Yiling Pharmaceutical in 2023
Eling Pharmaceutical: Notice on Receiving a Notice of Acceptance of Drug Registration Applications
Eling Pharmaceutical: Announcement on Approval of Converting Prescription Drugs to Non-Prescription Drugs for Lianhua QingCough Tablets
Yiling Pharmaceutical: An indicative announcement on the official release of the results of the Tongxinluo Myocardial Protection Research Project for the Treatment of Acute Myocardial Infarction
Eling Pharmaceutical: Rules of Procedure of the Board
Eling Pharmaceutical: Independent Director System
Eling Pharmaceutical: Announcement of Resolutions of the Eighth Meeting of the Eighth Board of Directors
Eling Pharmaceutical: Announcement on Foreign Donations
Eling Pharmaceutical: Remuneration and Appraisal Committee Work Rules
Eling Pharmaceutical: Working Rules of the Nomination Committee
Yiling Pharmaceutical: Announcement on Approval of the Clinical Trial Application for the Innovative Traditional Chinese Medicine, Huoxia Cold Granule Drug
Eling Pharmaceutical: Notice on Amending the “Articles of Association”
Yiling Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2023
Eling Pharmaceutical: Independent Directors\' Independent Opinions on Proposals Related to the Eighth Meeting of the Eighth Board of Directors
Eling Pharmaceutical: Audit Committee Work Rules
Eling Pharmaceutical: Notice on the pledge and cancellation of the pledge of some of the shares of the actual controller
Analysis
Price Target
No Data
